🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Crude Oil Moves Lower; Summit Therapeutics Shares Plummet

Published 20/02/2024, 19:33
© Reuters Crude Oil Moves Lower; Summit Therapeutics Shares Plummet
CL
-
IXIC
-
SMMT
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday.

The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The S&P 500 also fell, dropping, 0.73% to 4,969.26.

Check This Out: Top 4 Tech Stocks That May Crash This Month

Leading and Lagging Sectors

Consumer staples shares rose by 1.2% on Tuesday.

In trading on Tuesday, information technology shares fell by 1.8%.

Top Headline

The Conference Board's Leading Economic Index fell 0.4% for January, versus market expectations for a 0.3% decline.

Equities Trading UP

Monopar Therapeutics Inc. (NASDAQ: MNPR) shares shot up 90% to $0.6472 after the company announced it received Human Research Ethics Committee clearance in Australia to commence a Phase 1 dosimetry trial of its novel radiopharmaceutical MNPR-101-Zr.

Shares of Biofrontera Inc. (NASDAQ: BFRI) got a boost, surging 68% to $1.25 after the company announced a private placement of up to $16 million priced at the market per Nasdaq rules. Biofrontera ALSO announced restructuring of supply agreement with Biofronter AG.

TRxADE HEALTH, Inc. (NASDAQ: MEDS) shares were also up, gaining 94% to $8.04. TRxADE HEALTH announced the sale of assets of subsidiary Trxade, Inc. to Micro Merchant Systems for $22.5 million, with potential additional $7.5 million payout.

Equities Trading DOWN

RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares dropped 71% to $7.53 after the FDA verbally notified clinical hold on the company's Phase 2B trial of zelnecirnon in atopic dermatitis and Phase 2A trial in asthma.

Shares of Summit Therapeutics Inc. (NASDAQ: SMMT) were down 28% to $3.6505 after reporting fourth-quarter results.

Fluor Corporation (NYSE: FLR) was down, falling 11% to $37.26 following fourth-quarter results.

Also Check This Out: Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday

Commodities

In commodity news, oil traded down 1.9% to $77.72 while gold traded up 0.7% at $2,039.10.

Silver traded down 1.5% to $23.12 on Tuesday while copper rose 0.6% to $3.8620.

Euro zone

European shares closed mixed today. The eurozone’s STOXX 600 fell 0.10%, London’s FTSE 100 fell 0.12% while Spain’s IBEX 35 Index rose 0.94% The German DAX fell 0.14% French CAC 40 rose 0.34% while Italy’s FTSE MIB Index rose 0.08%.

Construction output in the Eurozone increased 1.9% from the prior year in December, recording the sharpest surge since February. The current account surplus in the Eurozone rose to €42.66 billion in December compared to €16.62 billion in the year-ago period. Passenger car registrations in the European Union jumped 12.1% year-over-year to 851.7 thousand units in January.

Asia Pacific Markets

Asian markets closed mostly higher on Tuesday, with Japan’s Nikkei 225 falling 0.28%, Hong Kong’s Hang Seng Index rising 0.57%, China’s Shanghai Composite Index gaining 0.42% and India’s S&P BSE Sensex gaining 0.5%.

Hong Kong’s unemployment rate came in unchanged at 2.9% in the three months ending January.

Economics

US leading index fell 0.4% for January, versus market expectations for a 0.3% decline.

Now Read This: Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.